U.S. Life Sciences Stock News

NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Five Below (FIVE) Same Store Sales Surge To 22.7% Tests Bullish Growth Narratives

Five Below (FIVE) has kicked off Q1 2027 with total revenue of US$1.3 billion and basic EPS of US$2.23, setting the tone for a results season where profitability and scale are front of mind for investors. The company has seen revenue move from US$970.5 million in Q1 2026 to US$1.3 billion in Q1 2027, while quarterly basic EPS shifted from US$0.75 to US$2.23 over the same period. This gives you a clear view of how the top and bottom lines are tracking. With trailing 12 month EPS at US$7.99 and...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

A Look At WillScot Holdings (WSC) Valuation After Quarterly Results Beat Analyst Expectations

WillScot Holdings (WSC) is back on investor radar after quarterly results came in ahead of analyst expectations on both revenue and earnings, with management pointing to continued progress on commercial and operational priorities. See our latest analysis for WillScot Holdings. At a share price of $26.48, the stock has a 1 month share price return of 15.94% and a 90 day share price return of 37.49%. However, the 1 year total shareholder return is down 2.35%, suggesting recent momentum is...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Karman Holdings’ Tripled $3b Pipeline Versus Lofty Valuation And Weak Momentum

Karman Holdings' active pipeline has tripled to around $3b since Q1 2025. The larger pipeline reflects higher demand across its aerospace and defense programs. This update highlights a material shift in Karman Holdings' future business opportunities. Karman Holdings (NYSE:KRMN) now has an active pipeline of about $3b, representing a significant change in its potential workload across aerospace and defense contracts. The stock last closed at $54.39 and is down 17.4% over the past week and...
NYSE:BHE
NYSE:BHEElectronic

Election Of New Director Puts Benchmark Electronics Governance In Focus

Benchmark Electronics (NYSE:BHE) shareholders elected David A. Moezidis to the Board of Directors at the company’s recent annual meeting. The board change introduces a new voice into Benchmark’s governance at a time when electronics manufacturing and engineering services continue to evolve. The appointment is a fresh corporate development that may influence future decisions on operations, capital allocation, and risk oversight. Benchmark Electronics focuses on providing engineering,...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Is It Time To Reconsider T. Rowe Price Group (TROW) After Its Recent 20.9% Gain?

If you are wondering whether T. Rowe Price Group at US$106.96 is priced attractively or not, the key question is how that tag compares with the company’s underlying value. The stock has returned 3.3% over the past week, 2.7% over the last month and 2.2% year to date, with a 20.9% return over the past year, while the 3 year return sits at 8.5% and the 5 year return reflects a 29.9% decline. Recent attention on T. Rowe Price Group has been shaped by ongoing interest in asset and wealth...
NasdaqGS:ONB
NasdaqGS:ONBBanks

A Look At Old National Bancorp (ONB) Valuation After New Shelf Registration Filings

Why Old National Bancorp Filed New Shelf Registrations Old National Bancorp (ONB) recently filed multiple shelf registrations covering common stock, debt, preferred stock, depositary shares, warrants, purchase contracts, and units, including a separate ESOP related common stock offering totaling US$216.9 million. These filings do not commit the company to issue securities immediately. Instead, they give management a framework to raise capital or restructure funding relatively quickly if and...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

A Look At Addus HomeCare (ADUS) Valuation After Recent Share Price Weakness

Recent share performance and valuation context Addus HomeCare (ADUS) has been under pressure recently, with the stock down about 9% over the past month and 13% over the past 3 months, leaving it roughly 16% lower year to date. Despite that pullback, the company reports annual revenue of US$1.45b and net income of US$99.75m. Its current share price of US$89.70 implies a market value of about US$1.62b. See our latest analysis for Addus HomeCare. The recent 1-day share price gain of 1.37% only...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is It Too Late To Consider Elanco Animal Health (ELAN) After Its 84% One-Year Surge?

If you are wondering whether Elanco Animal Health at around US$24.71 is priced for further upside or already reflecting high expectations, the valuation picture is where the real story starts. The stock has seen strong returns, with gains of 3.0% over 7 days, 7.5% over 30 days, 9.7% year to date and 84.0% over the past year, while the 3 year return is 164.3% and the 5 year return has declined 26.4%. Recent coverage has focused on how Elanco Animal Health is repositioning within animal health...
NasdaqGS:BYND
NasdaqGS:BYNDFood

How Beyond Meat’s Move Into Functional Beverages With Beyond Immerse (BYND) Has Changed Its Investment Story

Beyond Meat recently launched Beyond Immerse, a functional sparkling beverage line with plant protein, fiber, antioxidants, and electrolytes, into New York metro retail and foodservice locations via leading distributor Big Geyser. The move marks a meaningful expansion beyond plant-based meat into the fast-growing functional beverage space, potentially broadening Beyond Meat’s consumer reach and product mix. We’ll now examine how this push into functional beverages with Beyond Immerse could...
NYSE:AMCR
NYSE:AMCRPackaging

Amcor Expands Healthcare Packaging Reach With India Build And Puerto Rico Upgrade

Amcor (NYSE:AMCR) is expanding its Sira, Karnataka facility in India to support rising healthcare packaging demand in South Asia. The company has also secured new cleanroom certification at its Carolina, Puerto Rico plant for sterile healthcare packaging. These moves add capacity and certified sterile capabilities across two key regions for medical and pharmaceutical customers. Amcor, which last closed at $37.64 and has seen the share price decline 10.5% year to date and 11.6% over the past...
NYSE:CNMD
NYSE:CNMDMedical Equipment

A Look At CONMED (CNMD) Valuation After GI Exit, Guidance Raise And Debt Refinancing

CONMED (CNMD) is reshaping its focus after selling its gastrointestinal product portfolio and raising full-year organic growth guidance, while also taking on a new bank term loan that increases interest costs but extends financing flexibility. See our latest analysis for CONMED. The refinancing news and portfolio reshaping helped lift the share price, with a 1-day share price return of 6.26%. However, this follows weaker momentum, including a 30-day share price return down 4.12% and a 1-year...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Amazon Steps In At Globalstar As HIBLEO-4 Launch And Valuation Scrutinized

Amazon agreed to acquire Apple's stake in Globalstar as part of a multibillion dollar acquisition of the company, reshaping its ownership structure. Globalstar announced the HIBLEO-4 replenishment satellite launch to reinforce its low Earth orbit constellation. The developments come as Globalstar, ticker NasdaqGS:GSAT, trades around $82.65 per share. For investors watching satellite communications, Globalstar sits at an interesting point, with the stock up 29.2% year to date and showing a...
NasdaqGS:LINE
NasdaqGS:LINEIndustrial REITs

The Bull Case For Lineage (LINE) Could Change Following Portfolio Review And Deleveraging Plans - Learn Why

Lineage, Inc. recently presented at Nareit REITweek 2026, where CEO W. Gregory Lehmkuhl discussed a stable first quarter, reaffirmed full-year 2026 guidance and detailed ongoing investments in growth projects, technology and cost reduction initiatives. The company also outlined a portfolio review aimed at potential asset sales and joint ventures to improve financial flexibility and bring leverage toward its 5.0x to 5.5x target range, against a backdrop of early signs of stabilization in the...
NasdaqGS:WIX
NasdaqGS:WIXIT

Wix OpenAI Codex Tie Up Positions Platform For Agentic Commerce Growth

Wix.com (NasdaqGS:WIX) has partnered with OpenAI for the launch of Codex Enterprise. The collaboration enables users to deploy agentic commerce experiences using Wix Headless directly from Codex. The move expands Wix's role in AI-powered business creation and ties its platform more closely to OpenAI's enterprise stack. Wix.com has long focused on helping users build and manage online businesses, from websites and eCommerce to bookings and subscriptions. The tie up with OpenAI's Codex...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Assessing Webull (BULL) Valuation After Recent Share Price Rebound And Ongoing Growth Expectations

Recent performance context for Webull stock Webull (BULL) has drawn investor attention after a recent 3.4% single day gain, with a share price of $6.10 and mixed short term returns over the past week and month. See our latest analysis for Webull. The recent 1 day share price gain sits against a tougher backdrop, with the 30 day share price return down 16.8% and the 1 year total shareholder return down 41.5%. This suggests that recent momentum is still rebuilding from a weaker longer term...
NYSE:CI
NYSE:CIHealthcare

A Look At Cigna Group’s Valuation As Analysts Clash Over PBM Transition And Spending Uncertainty

Mixed analyst views put Cigna Group (CI) in focus Recent analyst actions on Cigna Group (CI), including a downgrade tied to its pharmacy benefit manager transition and spending plans, along with a more constructive view from another firm, have pushed the stock back onto investor watchlists. See our latest analysis for Cigna Group. Cigna Group shares have been volatile, with a 3-month share price return of 3.33% and a 1-year total shareholder return that declined 7.76%. This suggests that...
NYSE:OMC
NYSE:OMCMedia

Did Undervaluation Claims and Insider Selling Just Recast Omnicom Group's (OMC) Risk‑Reward Narrative?

In recent days, Omnicom Group has drawn fresh attention as independent analyses flagged the stock as trading at a meaningful discount to estimated intrinsic value, even as insider transactions have tilted toward modest selling. This combination of perceived undervaluation and insider caution is sharpening the market’s focus on how effectively Omnicom can convert its fundamental strengths into durable financial outcomes. We’ll now explore how this perceived undervaluation, alongside insider...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Celcuity Expands VIKTORIA-2 Trial As Shares Trade Below Targets

Celcuity (NasdaqCM:CELC) amended its pivotal Phase 3 VIKTORIA-2 trial to add a new cohort for endocrine-sensitive breast cancer. The company is also developing a subcutaneous formulation of gedatolisib to offer a more convenient treatment option. These updates extend the clinical reach of VIKTORIA-2 beyond previously discussed trial and financing milestones. For investors tracking Celcuity, the latest clinical updates come after a sharp pullback in the share price, which is down 29.4% over...
NYSE:JLL
NYSE:JLLReal Estate

JLL’s Lake Austin Loan Highlights Fee Based Role In Luxury Projects

JLL Capital Markets, part of NYSE:JLL, arranged an $870 million senior loan for Four Seasons Private Residences Lake Austin. The financing supports one of Austin's highest profile luxury residential projects, featuring branded residences with extensive amenities. The deal involves multiple co advisors and places JLL in a central role in a major Texas luxury real estate development. For investors watching NYSE:JLL, this transaction offers a concrete example of how the company participates in...
NYSE:TDC
NYSE:TDCSoftware

Teradata Unites Data AI And Technology Roles As Investors Weigh Execution

Teradata (NYSE:TDC) has combined its Chief Data and AI Officer and Chief Information Officer roles under Josh Fecteau. The move brings Data, AI, and Technology Services under one leader to support modernization and integrated AI execution. The consolidation is positioned as an internal transformation aimed at tighter coordination across Teradata's technology stack. For investors watching NYSE:TDC, this leadership shift arrives with the stock at $34.88 and a mixed recent track record. The...
NYSE:BMI
NYSE:BMIElectronic

Badger Meter Lawsuits Put Demand Narratives And Governance Under Scrutiny

Multiple law firms have launched investigations and class action lawsuits against Badger Meter (NYSE:BMI). The actions focus on allegations that the company misrepresented demand trends, order patterns, and its financial outlook to investors. The wave of filings points to concerns about Badger Meter's disclosures, management credibility, and governance practices. Badger Meter, a manufacturer of flow measurement and control technologies for water and other fluids, sits at the intersection of...
NYSE:CC
NYSE:CCChemicals

Chemours Award Highlights Research Culture And Long Term Investor Considerations

Chemours (NYSE:CC) has launched its inaugural Catalyst for Scientific Excellence Award. The new company-level award recognizes internal researchers for their contributions to innovation and knowledge sharing. The program is designed to highlight and reward scientific progress across Chemours' global operations. Chemours is putting a spotlight on its research talent at a time when the stock is trading at $21.67. The shares are up 76.9% year to date and 107.7% over the past year, despite...
NasdaqCM:SERV
NasdaqCM:SERVHospitality

Is Serve Robotics (SERV) Expanding Beyond Food Delivery a Strategic Edge or a Costly Distraction?

Serve Robotics Inc. recently announced a new partnership with on-demand laundry service NoScrubs, launching a commercial pilot in select Los Angeles neighborhoods that uses its existing fleet of approximately 500 local robots to deliver laundry directly to customers’ doors outside its core prepared-food business. This move extends Serve’s autonomous sidewalk delivery model into recurring local commerce beyond food, using the same robots and operations to improve fleet utilization by filling...
NYSE:BG
NYSE:BGFood

Should Negative Free Cash Flow And Dilution Risks Require Action From Bunge Global (BG) Investors?

In recent days, Bunge Global has come under pressure after reporting negative free cash flow and declining earnings per share, despite maintaining relatively steady sales growth and an unfavorable liquidity profile. Investors are increasingly focused on the possibility that ongoing weak cash generation could force the company to pursue equity financing that would dilute existing shareholders. We will now explore how these concerns about negative free cash flow and potential dilution could...